FDA Said Wellbutrin Generic Drugs Are Not Same as Original-Truth!
Summary of eRumor:
News stories are circulating the Internet alleging that the Food and Drug Administration reversed course on a ruling that two generic forms of the prescription anti-depressant drug Wellbutrin were the same as the original.
This is true according to an October 10 2013 announcement found on the website of the Food and Drug Administration (FDA). It said that two generic forms of Wellbutrin do not have the same therapeutic effect as the original antidepressant manufactured by GlaxoSmithKline.
The FDA announcement said that testing revealed that Budeprion XL 300 mg tablets made by Impax Laboratories, Inc., and marketed by Teva Pharmaceuticals USA, Inc., were not the same as Wellbutrin XL 300 mg tablets. Likewise, Budeprion HCL ER 300 mg tablets made by Watson Pharmaceuticals, Inc., were also different from the original.
Both companies volunteered to remove the drugs from the market. The FDA recommended that anyone taking a Wellbutrin generic manufactured by one of those two companies continue to take the medication and notify their health care provider.
The FDA’s announcement did not apply to Wellbutrin generics made by Actavis, Inc., Mylan, Inc., and Par Pharmaceutical. Generic drugs produced by those companies have the same therapeutic effect as the name brand drug.